Conceptual, methodological, and ethical problems of placebo groups in psychotherapy research.
Conceptual, methodological, and ethical problems of placebo groups in psychotherapy research.
复制标题
心理治疗研究中安慰剂组的概念、方法论和伦理问题。
DOI：
10.1037//0003-066x.33.9.821
复制
发表时间：
1978
期刊：
影响因子：
--
通讯作者：
T. Borkovec
中科院分区：
文献类型：
--
作者：
K. O'Leary;T. Borkovec
心理治疗研究者早就认识到需要控制预期效应、治疗师接触和治疗师注意力，并且通常将这些治疗因素归入安慰剂效应的范畴。作者认为，必须将控制这些因素的必要性与安慰剂组的必要性区分开来。在中等或更长时间的心理治疗研究中，满足经典标准的心理治疗安慰剂组（即，理论上惰性的程序，没有特定的活性）可能是不道德的，不切实际的，或者方法上不合理的。作者建议放弃安慰剂组这一术语，并使用替代疗法，如”最佳可用”疗法、成分控制条件、中性预期控制和反需求操纵。本文讨论了心理治疗研究中采用等待列表控制的必要性。(26参考）（PsycINFO数据库记录（c）2016阿帕，保留所有权利）
Psychotherapy researchers have long recognized the need to control for expectancy effects, therapist contact, and therapist attention and have generally subsumed these therapeutic factors under the placebo effect rubric. The authors suggest that the need to control for such factors must be distinguished from the necessity for a placebo group. A psychotherapy placebo group that meets the classic criteria (ie, a theoretically inert procedure without specific activity for the condition being treated) may be unethical, impractical, or methodologically unsound in psychotherapy research of moderate or greater length. The authors suggest that the term placebo group be abandoned and that alternatives, such as" best available" therapies, component control conditions, neutral expectancy controls, and counterdemand manipulations, be used. The necessity for wait-list controls in psychotherapy research is discussed.(26 ref)(PsycINFO Database Record (c) 2016 APA, all rights reserved)